muscle loss with semaglutide Weight-loss drug found to shrink heart in mice and human cells New research shows adults using

Later, it was approved for use in individuals with a body mass index (BMI) of 27 or above weight gain and those with at least one weight-related health problem, such as high blood pressure or type 2 diabetes, to promote weight loss

Its already known that semaglutide GLP-1 drugs influence feelings of fullness, but scientists are now wondering whether changes in the brain and tongues processing of taste might explain why some users report reduced cravings for sugary or rich foods

The most effective treatment is not always the one with the biggest weight loss number in a study

Additionally, GLP-1 receptor activation affects gastrointestinal motility more broadly, potentially leading to altered bowel habits

: :-